PETS vs RDGT
Petmed Express Inc. and Ridgetech Inc., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | PETS | RDGT |
|---|---|---|
| Revenue | $179.0M | $132.2M |
| Net income | $-57.3M | $-1.3M |
| Gross margin | 28.1% | 3.6% |
| Net margin | −32.0% | −0.9% |
| Return on equity | −100.4% | −4.2% |
| Diluted EPS | −$2.74 | −$17.21 |
| Dividend / share | $0.00 | — |
| Payout ratio | −0.0% | — |
| Free cash flow | $-33.0M | $-1.4M |
| Equity | $28.9M | — |
| Net debt / equity | — | — |
| Current ratio | 0.84× | 2.31× |
| Revenue CAGR 5y | −10.0% | −0.1% |
| Profit CAGR 5y | — | — |
PETS bills 1.4× the revenue of RDGT, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
7 years side by side
| Fiscal year | PETS | RDGT |
|---|---|---|
| FY2025 | $179.0M | $132.2M |
| FY2024 | $227.0M | $120.0M |
| FY2023 | $274.1M | $124.0M |
| FY2022 | $247.6M | $120.2M |
| FY2021 | $272.3M | $164.4M |
| FY2020 | $303.6M | $133.1M |
| FY2019 | $284.1M | $117.3M |
Net income by year
Bottom line
| Fiscal year | PETS | RDGT |
|---|---|---|
| FY2025 | $-57.3M | $-1.3M |
| FY2024 | $-6.3M | $10.2M |
| FY2023 | $-7.5M | $-4.2M |
| FY2022 | $5.1M | $-21.1M |
| FY2021 | $18.7M | $-3.2M |
| FY2020 | $23.9M | $-8.1M |
| FY2019 | $25.9M | $-5.8M |
More in this industry